Screener
PACS Group PACS Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by PACS Group in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: PACS Group’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002001184-26-000023
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| NET CASH USED IN FINANCING ACTIVITIES | $(67,714) | $(4,065) |
| Net change in cash | 41,660 | 129,763 |
| Cash, cash equivalents, and restricted cash - beginning of period | 232,051 | 160,842 |
| Cash, cash equivalents, and restricted cash - end of period | $273,711 | $290,605 |
| Cash and cash equivalents | $247,981 | $287,512 |
| Restricted cash (included in prepaid expenses and other current assets) | 25,730 | 3,093 |
| Cash, cash equivalents, and restricted cash | $273,711 | $290,605 |
| Supplemental disclosures of cash flow information |
Item 1. Financial Statements (unaudited)
FAQ
- What is PACS Group's cash & equivalents?
- PACS Group (PACS) reported cash & equivalents of $273.71M in Q1 2026.
- How has PACS Group's cash & equivalents changed year-over-year?
- PACS Group's cash & equivalents decreased by 5.8% year-over-year, from $290.61M to $273.71M.
- What is the long-term trend for PACS Group's cash & equivalents?
- Over 4 years (2021 to 2025), PACS Group's cash & equivalents has grown at a 35.6% compound annual growth rate (CAGR), from $68.56M to $232.05M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about PACS Group's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude